[Administration of statins during the acute phase of acute coronary syndrome].
The benefits of statins in patients with stable coronary syndrome is indisputable, however their early use in acute coronary syndrome (ACS) is under debate. There are few existing clinical trials and meta-analysis results on this and their results provide little clarification. However, most of the registries have found them to be efficient. There are no studies that show this therapy to be unsafe, so its inclusion in treatment guidelines during the acute phase of ACS could be studied.
Ruiz-Bailén
M
M
Unidad de Medicina Intensiva, Servicio de Cuidados Críticos y Urgencias, Departamento de Ciencias de la Salud, Complejo Hospitalario de Jaén, Universidad de Jaén, Jaén, España. ruizbailen@telefonica.net
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000401:mortality; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors